A new study led by University of California, Irvine (UCI) researchers identifies two ways in which APOBEC3A— a vital enzyme that is responsible for genetic changes resulting in a variety of cancers while protecting our ...
Aug 13, 2021
0
757
Drugs that target specific proteins have greatly improved patient outcomes across a broad range of tumor types; however, patients often develop drug resistance and tumor recurrence. There is a great unmet need to identify ...
Jul 29, 2021
0
36
Some antibiotics appear to be effective against a form of skin cancer known as melanoma. Researchers at KU Leuven, Belgium, examined the effect of these antibiotics on patient-derived tumors in mice. Their findings were published ...
Jul 22, 2021
0
12
Cancer cells have an uncanny ability to evolve and adapt to overcome the treatments used against them.
Jun 18, 2021
0
16
A drug currently used to prevent organ rejection in transplants could also reduce chemotherapy resistance in glioblastoma, according to a Northwestern Medicine study published in Brain.
Jun 17, 2021
0
10
New research from the University of Salford shows that cutting off the fuel supply can effectively stop the spread of cancer cells.
Jun 2, 2021
0
980
Scientists can use genetic 'weather forecasting' to predict how long it will take for bowel cancer to evolve resistance to a drug before a patient has even started treatment, a new study has shown.
May 21, 2021
0
24
The COVID-19 pandemic has reinforced the pressing need to mitigate a fast-developing virus as well as antibiotic-resistant bacteria that are growing at alarming rates worldwide.
May 18, 2021
0
37
Low doses of a four-drug combination helps prevent the spread of cancer in mice without triggering drug resistance or recurrence, shows a study published today in eLife.
May 11, 2021
0
9
T-cell acute lymphoblastic leukemia (T-ALL) is a very aggressive type of blood cancer. It is relatively rare but still draws a lot of attention as it mostly develops in children under the age of 20. The standard treatment ...
May 4, 2021
0
34
